Aurobindo Pharma Ltd (NSE:AUROPHARMA) Share Price

Company Profile

Business description
Aurobindo Pharma Ltd is a specialty and generic drug manufacturing company. It is principally engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Its formulations target key therapeutic areas, including Central Nervous System (CNS), Antibiotics, Anti-diabetics, Cardiovascular, Anti-retroviral, Gastroenterology, Oncology, and Dermatology. The operating and reportable segments of the company are; India, the United States of America, Europe, and the Rest of the World. The company generates a majority of its revenue from its business in the United States of America.
Contact
Plot No. 1, Survey No. 83/1
Galaxy, Floors 22-24
Hyderabad Knowledge City
Raidurg Panmaktha, Ranga Reddy District
HyderabadTG500032
IND
T: +91 4066725000
https://www.aurobindo.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
40,750

Recommended

IFM lobs reasonable takeover offer.

Adrian Atkins | 28 April 2026

Microsoft, Amazon, Alphabet, and Meta will all release quarterly earnings. Here’s what analysts are looking for.

Jillian Moore | 28 April 2026

Corning’s optical fiber business is thriving, and the Meta deal derisks its supply buildout, but success isn’t guaranteed.

Ananya Chag | 27 April 2026

Index	Last price	Change	% Change
All Ordinaries	8,915.70	16.00	0.18%
CAC 40	8,072.13	31.96	-0.39%
DAX 40	23,954.56	63.70	-0.27%
Dow JONES (US)	48,825.78	316.15	-0.64%
FTSE 100	10,213.11	119.68	-1.16%
HKSE	26,111.84	432.06	1.68%
NASDAQ	24,609.25	54.55	-0.22%
Nikkei 225	59,917.46	619.90	-1.02%
NZX 50 Index	12,770.30	5.90	0.05%
S&P 500	7,126.59	12.21	-0.17%
S&P/ASX 200	8,687.00	9.40	0.11%
SSE Composite Index	4,107.51	28.88	0.71%